Abstract
Currently, under the law of intellectual property, IP owners may exclude from use or production substances and processes that we would ordinarily consider to be products of nature. This has helped companies monopolize disease genes, and thus diagnostic testing for those diseases, and “biosimilar” products, pharmaceutical materials that mimic biological materials. Extending the current paradigm to the world of synthetic biology and nanotechnology will create further injustices in the delivery of health care to billions of people around the world. As such, I advocate heading this trend off at the pass. Scientists ought to conduct basic research into the building blocks of biology and matter in the open, publishing their results, releasing knowledge into the public domain upstream so that beneficial innovation can be produced without fear of downstream litigation, and so that what ought to remain in the public domain as a matter of right (products of nature) does not become unjustly monopolized.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
And arguably a third sort of thing we might call ‘accidents’.
- 2.
For more on Basic Formal Ontology, see <http://www.ifomis.org/bfo/1.1> [accessed 22 September 2010].
References
Copi I (2001) An introduction to logic. Prentice Hall, New Jersey
Koepsell D (2000) The ontology of cyberspace: law, philosophy, and the future of intellectual property. Open Court, Chicago
Koepsell D (2009) Who owns you: the corporate gold rush to patent your genes. Wiley Blackwell
Locke J (1690) Second Treatise of Government, edited, with an Introduction, By C.B. McPherson. Hackett Publishing Company, Indianapolis/Cambridge, 1980
Munn K, Smith B (2008) Applied ontology: an introduction. Ontos Verlag, Frankfurt, p 268
Simons P, Melia J (2000) Continuants and occurrents. Proc Aristot Soc Suppl Vol 74:59–75, 77–92
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Koepsell, D. (2014). Synthetic Biology and IP: How Do Definitions of “Products of Nature” Affect their Implications for Health?. In: de Miguel Beriain, I., Romeo Casabona, C. (eds) Synbio and Human Health. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9196-0_4
Download citation
DOI: https://doi.org/10.1007/978-94-017-9196-0_4
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-9195-3
Online ISBN: 978-94-017-9196-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)